Adaptive Biotechnologies Statistics
NASDAQ: ADPTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
27.93-0.12 (-0.43%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Adaptive Biotechnologies by the numbers
Adaptive Biotechnologies has a market capitalization of $4.52 billion based on 161.88M shares outstanding. With trailing EPS of $-0.45, Adaptive Biotechnologies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.3% above its 50-day average and 37.3% above its 200-day average.
Average daily trading volume is 2.20M shares, or about $61.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADPT valuation vs. peer median
| Metric | ADPT | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.52B | $3.38B | +34% |
| Avg. volume | 2.20M | 1.80M | +22% |
Peer median across 8 companies: CRSP, TARS, RLAY, SRRK, IOVA, DNLI, VCEL, ADMA.
Valuation
- Market cap
- $4.52B
- Price / sales (latest FY)
- 16.32
- EPS (TTM)
- $-0.45
- Shares outstanding
- 161.88M
Price and trading
- Previous close
- 28.05
- Open
- 27.43
- Day range
- 27.15 – 28.23
- 52-week range
- 12.00 – 32.21
- 52-week change
- +50.08%
- Beta
- —
- Volume
- 2.48M
- Average volume
- 2.20M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 4.52B
- Forward Pe
- -837.98
- Eps
- -0.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 32.21
- Week52 Low
- 12.00
- Avg Volume
- 2.20M
- Shares Outstanding
- 161.88M
- Ma50
- 27.29
- Ma200
- 20.35
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -13.29%
- Pct From52w Low
- 132.75%